MNST

Monster Beverage
Soft Drinks & Non-alcoholic Beverages · Consumer Staples · as of 2026-10-05
Last close
$43.51
+1.3% on the session
1-year return
+28.8%
+17.3% over six months
Volatility
26.7%
annualized, trailing year
Max drawdown
-17.7%
worst peak to trough, 1y
What the numbers say

Monster Beverage is a soft drinks & non-alcoholic beverages name in the consumer staples sector. Over the past year it returned +28.8%, against -10.2% over three months and -1.3% over one. It sits just 2.6% above its 200-day average, technically in an uptrend, but without much room. Annualized volatility of 26.7% is moderate by single-stock standards.

Its worst peak-to-trough decline over the year was -17.7%, and it has traded a median $443M a day, the figure that decides whether a position can actually be entered and exited at posted prices. Its daily moves correlate 0.11 with the S&P 500 proxy, so it has been moving substantially on its own.

Where it ranks
Within Consumer Staples#9 of 34
Stronger than 76% of its sector on the momentum profile
Across the whole index#220 of 496

How MNST scores on all four profiles

Its standing on steadiness, defensiveness and rebound, plus the factor-by-factor breakdown behind each score, and its closest and least-correlated peers among 3 others in Soft Drinks & Non-alcoholic Beverages.

Start a free 7-day trial
Full metrics
1 day+1.3%
1 week+3.9%
1 month-1.3%
3 months-10.2%
6 months+17.3%
1 year+28.8%
12-1 momentum+30.5%
Volatility (1y, annualized)26.7%
Max drawdown (1y)-17.7%
Distance vs 200-day average+2.6%
Return per unit of risk1.08
Median daily dollar volume$443M
Free newsletter

Get MNST when it shows up in a ranking

Two editions a weekday, free, ranked lists built from this same data, on whatever the market is talking about.

Everything on this page is computed from daily adjusted closing prices. It contains no earnings, balance-sheet, guidance or ownership data, and it is not a valuation. Nothing here is tailored to your circumstances or a recommendation to buy or sell. Past performance does not predict future results.